Proto Labs, Inc. (PRLB)

From the record

Proto Labs, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Proto Labs, Inc.'s 10 filed years say what it did: revenue went from $298 million in fiscal 2016 to $533 million in fiscal 2025, up 6.7% a year; it rose in 7 of 9 years; the deepest fall was 5% from fiscal 2019 to fiscal 2020; net income was positive in 9 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Proto Labs, Inc.'s diluted share count shrank about 4.0% a year, and dividends and buybacks returned about 65% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 15 sales (13 under scheduled 10b5-1 plans) and 2 purchases of their own stock on the open market in the year to 2026-11-04, buying about $101 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Proto Labs, Inc. earned about 3 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 31 cents per dollar of everything the company owns. Leverage: it owed about 12 cents per dollar of assets, and net share issuance: its share count shrank 3.8% over the year (the filed statements).

From the record

Proto Labs, Inc.'s standing among 35 graded names in its industry family: revenue of $533 million in fiscal 2025 ranks in the bottom 41% by size; a net margin of 4% ranks in the top 50%; revenue growth of 3% a year over the last 3 filed years ranks in the top 34% (its annual reports).

From the record

Proto Labs, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Krishna, Suresh (President and CEO, as filed), filing under that title since 2025-05-28, 1.5 years (bottom 18% of its family); the 12 officers and directors filing in the last fifteen months have been on the record a median of 6.3 years (bottom 48%); 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 12 people in charge now (bottom 19%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Proto Labs, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $111 million against no long-term debt tagged leaves 14.5% of its assets as net cash, top 21% of its family; cash from operations less capital spending is 11.2% of revenue (top 30%); a gross margin of 44.5% (top 15%); research spending of 8% of revenue (top 22%) (its annual report).

From the record

Proto Labs, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 3% a year over the last three filed years against 6.7% over all 10, slowing (top 47% of its family); the newest year grew 6.4% (top 34%); research spending grew 3.8% a year (bottom 47%); capital spending grew -11.9% a year (bottom 38%) (its annual reports). Proto Labs, Inc. reported 2 lines of business in fiscal 2025: United States at $432 million (81%), Europe at $101 million (19%); 1 of 2 grew against the year before (its annual report).

From the record

Proto Labs, Inc.'s newest year against its own record: revenue of $533 million in fiscal 2025 came in 5.1% above the $507 million its prior three years' pace pointed to (bottom 49% of its family); net income of $21 million against a prior three-year average of $23 million (top 4%); a net margin of 4% against -4.8% before (top 16%) (its annual reports).